Case reportCureusPublished
Severe Dermatologic Toxicity During Amivantamab-Lazertinib Treatment in Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Regional connection
Verified Author affiliations on the Europe PMC record name Cooper Norcross Health, Cooper Medical School of Rowan University, with Rowan University linked by the institution reference. Affiliation source
- County
- Camden County
Publication record
- Type
- Case report
- Venue
- Cureus
- Published
- Topic
- Clinical care
- Subject terms
- Non-small cell lung cancer (NSCLC); Epidermal Growth Factor Receptor (Egfr); Cutaneous Adverse Drug Reaction; Lazertinib; Amivantamab
- PubMed ID
- 42824853
- PubMed Central ID
- PMC13629737
- Open access
- Yes, open
- Added to directory
- Source checked